Cargando…
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
In the last decade, it has become apparent that toll-like receptor (TLR) signaling can play an important role in ovarian cancer (OC) progression. Interestingly, TLR activation in immune cells can help activate an anti-tumor response, while TLR signaling in tumor cells themselves is often associated...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105689/ https://www.ncbi.nlm.nih.gov/pubmed/25101083 http://dx.doi.org/10.3389/fimmu.2014.00341 |